Jiangsu

600276.SS

Tags: CN Healthcare Drug Manufacturers - General

Jiangsu Hengrui Medicine Price (600276.SS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

6,327,111,662

(0.6265)%

Market Cap of Jiangsu (600276.SS)

Market cap:

As of , 600276.SS has a market cap of . This makes 600276.SS the 28th most valuable company in the CN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $37.24-57.53
Market Cap 295.25B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - General

ceo: Mr. Hong Bin Dai
IPO Date: October, 18, 2000
Country: CN
Currency: CNY
Headquaters: No Data
Employees: 19611

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: